Overall, these data suggest that increased expression of CSF-1 in EBV-associated tumour cell CM can upregulate CCR5 receptor expression on monocytes and migration towards increased CCL5 in EBV-associated tumour cell CM. The gene discussed is CCL5; the disease is neoplasm.